Impact Factor 2023
The Impact Factor 2023 for the UiM/EJU is 3.1
UiM/EJU subscribers
are now provided with
a mobile digital issue
of their journal.
The eRef app enables
you to comfortably
read the latest journal issues on your tablet.
Find out more about the eRef app here
Use UiM/EJU offline • optimal reading experience • scalable font size • one click to download UiM/EJU
Ultrasound International Open
New open-access journal!
For author instructions and further information about publishing in UIO, visit www.thieme.com/uio
EFSUMB on FACEBOOK
EFSUMB NEWS
|
More information on all EUROSON Schools can be found on www.efsumb.org >>
European Journal of Ultrasound 01-2025
Bitterer F, Bauer A, Glehr G et al.
Complete resection of the affected tissue remains the best curative treatment option for liver-derived tumors and colorectal liver metastases. In addition to preoperative cross-sectional imaging, contrast-enhanced intraoperative ultrasound (CE-IOUS) plays a crucial role in the detection and localization of all liver lesions. However, its exact role is unclear. This study was designed to evaluate the clinical and oncological impact of using CE-IOUS in the surgical treatment of these diseases.
Zadeh ES, Görg M, Görg C et al.
To evaluate the diagnostic yield of contrast-enhanced ultrasound (CEUS)-guided biopsy of retroperitoneal masses (RMs). Between 2006 and 2023, 87 patients presented at our US center for biopsy of an RM. In all biopsies, CEUS was performed prior to the intervention. The technical success rate of biopsy, the presence of diagnostic tissue in solid tumor biopsy samples, the accuracy of the biopsy and the occurrence of post-interventional complications were evaluated.